Krishna Institute of Medical Sciences Limited has informed the Exchange regarding a press release dated May 16, 2026, titled "Press Release".
KIMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
KIMS Hospitals reported total revenue of INR 1,084 Cr for Q4 FY26, up 35.3% YoY, and INR 3,931 Cr for full year FY26, up 28.2% YoY. However, profitability metrics showed significant deterioration with PAT declining 41.7% to INR 242 Cr for FY26 from INR 415 Cr in FY25. EBITDA margin compressed to 21.1% from 26.6% in FY25. The decline in profits is attributed to a 124% surge in interest costs to INR 202.5 Cr and 60% increase in depreciation to INR 283.2 Cr, driven by expansion into four new hospitals in Bengaluru, Kerala, and Thane. Operational metrics remained strong with IP volume up 15.4% and OP volume up 25.4% YoY. The company operates 26 hospitals with over 7,300 beds across five states.
The stock may face pressure despite revenue growth due to sharp PAT decline and margin compression from high debt costs related to expansion. Investors should monitor whether new hospitals achieve profitability targets in FY27 as management stated.